The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
The importance of glycemic equipoise in NASH
Hepatology. 2021 Apr 26. doi: 10.1002/hep.31866. Online ahead of print.
Alina M Allen1, Brent A Neuschwander-Tetri2
Author information
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
2Division of Gastroenterology and Hepatology, Saint Louis University, Saint Louis, MO, USA.
Abstract
Insulin resistance is a key pathogenic driver in NAFLD. Approximately one quarter of patients with NAFLD and 44% of those with NASH have type 2 diabetes mellitus (DM) (1) while an additional substantial proportion of those without DM have impaired fasting glucose.